OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS by T. V. Dokukina, M. V. Makhrov, I. V. Gaidukevich, A. A. Gilep, T. S. Golubeva, F. P. Khlebokazov, N. N. Misyuk, P. P. Korolevich

Get full text

Evaluation of the effectiveness of electroconvulsive therapy in the treatment of psychosis in a patient with epilepsy. Clinical case by T. V. Dokukina, F. P. Khlebokazov, I. I. Khvostova, N. N. Misyuk, K. A. Bondar, P. P. Korolevich, E. L. Slobina, I. S. Glavinskiy

Get full text

Use of autologous mesenchymal stem cells in the combined treatment of symptomatic epilepsy by F. P. Khlebokazov, T. V. Dokukina, N. Yu. Paramonova, S. I. Gotto, I. I. Khvostova, N. N. Misyuk, A. I. Martynenko, Е. L. Slobina, I. V. Shamruk

Get full text

THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING by T. V. Dokukina, A. I. Startsev, M. V. Makhrov, I. V. Haidukevich, T. S. Golubeva, A. A. Gilep, E. A. Sheremet, I. V. Shamruk, A. S. Pinchuk, S. A. Marchuk, F. P. Khlebokazov, N. N. Misyuk

Get full text

OUR EXPERIENCE IN APPLICATION OF AUTOLOGOUS BONE-MARROW-DERIVED MESENCHYMAL STEM CELLS FOR THERAPY OF PATIENTS WITH SYMPTOMATIC EPILEPSY by F. P. Hlebokazov, T. V. Dоkukina, S. I. Ighnatenko, S. M. Кosmacheva, N. V. Goncharova, M. P. Potapnev, M. V. Makhrov, P. P. Korolevich, N. N. Misyuk, I. V. Grigorieva, S. A. Marchuk

Get full text